BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23908345)

  • 1. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.
    Ge S; Hertel B; Koltsova EK; Sörensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S
    Circ Res; 2013 Sep; 113(8):965-74. PubMed ID: 23908345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
    Wan W; Liu Q; Lionakis MS; Marino AP; Anderson SA; Swamydas M; Murphy PM
    Cardiovasc Res; 2015 Jun; 106(3):478-87. PubMed ID: 25858253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
    Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
    Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
    Madhur MS; Funt SA; Li L; Vinh A; Chen W; Lob HE; Iwakura Y; Blinder Y; Rahman A; Quyyumi AA; Harrison DG
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1565-72. PubMed ID: 21474820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.
    Butcher MJ; Gjurich BN; Phillips T; Galkina EV
    Circ Res; 2012 Mar; 110(5):675-87. PubMed ID: 22302786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
    Xu L; Dai Perrard X; Perrard JL; Yang D; Xiao X; Teng BB; Simon SI; Ballantyne CM; Wu H
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1787-97. PubMed ID: 26112011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.
    Dong L; Nordlohne J; Ge S; Hertel B; Melk A; Rong S; Haller H; von Vietinghoff S
    J Am Soc Nephrol; 2016 Jun; 27(6):1753-64. PubMed ID: 26449606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice.
    Engelbertsen D; To F; Dunér P; Kotova O; Söderberg I; Alm R; Gomez MF; Nilsson J; Bengtsson E
    Exp Diabetes Res; 2012; 2012():176162. PubMed ID: 23243415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation.
    Cremer S; Michalik KM; Fischer A; Pfisterer L; Jaé N; Winter C; Boon RA; Muhly-Reinholz M; John D; Uchida S; Weber C; Poller W; Günther S; Braun T; Li DY; Maegdefessel L; Perisic Matic L; Hedin U; Soehnlein O; Zeiher A; Dimmeler S
    Circulation; 2019 Mar; 139(10):1320-1334. PubMed ID: 30586743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
    Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
    J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.